Clearside Biomedical President and Chief Executive Office George Lasezkay's 2021 pay jumps 71% to $2.3M
Clearside Biomedical reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Clearside Biomedical reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, three executives at Clearside Biomedical received on average a compensation package of $1.9M, a 113% increase compared to previous year.
George Lasezkay, President and Chief Executive Office, received $2.3M in total, which increased by 71% compared to 2020. 40% of Lasezkay's compensation, or $943K, was in option awards. Lasezkay also received $36K in bonus, $268K in non-equity incentive plan, $516K in salary, $562K in stock awards, as well as $16K in other compensation.
Thomas Ciulla, Chief Medical Officer, received a compensation package of $1.8M, which increased by 172% compared to previous year. 45% of the compensation package, or $822K, was in option awards.
Charles A. Deignan, Chief Financial Officer, earned $1.5M in 2021, a 141% increase compared to previous year.